Time benefit in the assessment of recurrences following fractionated radiotherapy in an experimental tumour system using positron-emission tomography with 18F-fluorodeoxyglucose

International Journal of Radiation Biology

Volumn 80, Issue 7, 2004, Pages 529-539

  De Wit, M ^a   Raabe, A ^a   Seegers, B ^a   Buchert, R ^a   Beck Bornholdt, H P ^a   Alberti, W ^a   Hossfeld, D K ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; DIAGNOSTIC ACCURACY; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR; TUMOR RECURRENCE;

ANIMALS; DOSE FRACTIONATION; FLUORODEOXYGLUCOSE F18; NEOPLASM RECURRENCE, LOCAL; RATS; RHABDOMYOSARCOMA; ROC CURVE; SARCOMA, EXPERIMENTAL; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA;

EID: 3843082952     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/09553000410001723875     Document Type: Article

References (35)

1. BECK-BORNHOLDT, H. P., MAURER, T., BECKER, S., OMNICZYNSKI, M., VOGLER, H. and WüRSCHMIDT, F., 1989, Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation - 126 fractions applied within 6 weeks. International Journal of Radiation Oncology, Biology, Physics, 16, 701-705.
2. BEGGS, A. D., HAIN, S. F., CURRAN, K. M. and O'DOHERTY, M. J., 2002, FDG-PET as a 'metabolic biopsy' tool in non-lung lesions with indeterminate biopsy. European Journal of Nuclear Medicine and Molecular Imaging, 29, 542-546.
3. BRAMMER, I., ZYWIETZ, F., BECK-BORNHOLDT, H. P. and JUNG, H., 1992, Kinetics of depopulation, repopulation and host cell infiltration in the rhabdomyosarcoma R1H after 14 MeV neutron irradiation. International Journal of Radiation Biology, 61, 703-711.
4. BUMANN, D., DE WIT, M., BEYER, W., BEESE, M., LÜBECK, M., BÜCHELER, E. and CLAUSEN, M., 1998, Computer-tomographie und F-18-FDG Positronen-Emissions-Tomographie im Staging maligner Lymphome: ein Vergleich. Fortschritte auf dem Gebiet der Röntgenstrahlen, 168, 457-465.
5. DE WIT, M., BUMANN, D., BEYER, W., HERBST, K. and HOSSFELD, D. K., 1997, Whole-body positron-emission tomography (PET) for diagnosis of residual mass in patients with lymphoma. Annals of Oncology, 8, 57-60.
6. DEWAN, N. A., GUPTA, N. C., REDEPENNING, L. S., PHALEN, J. J. and FRICK, M. P., 1993, Diagnostic efficacy of PET-FDG Imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest, 104, 997-1002.
7. HAIN, S. F., CURRAN, K. M., BEGGS, A. D., FOGELMAN, I., O'DOHERTY, M. J. and MAISEY, M. N., 2001, FDG-PET as 'metabolic biopsy' tool in thoracic lesions with indeterminate biopsy. European Journal of Nuclear Medicine, 28, 1336-1340.
8. HIGASHI, T., SAKAHARA, H., TORIZUKA, T., NAKAMOTO, Y., KANAMORI, S., HIRAOKA, M., IMAMURA, M., NISHIMURA, Y., TAMAKI, K. and KONISHI, J., 1999, Evaluation of intraoperative radiation therapy for unresectable pancreatic cancer with FDG PET. Journal of Nuclear Medicine, 40, 1424-1433.
9. JUNG, H., BECK, H. P., BRAMMER, I. and ZYWIETZ, F., 1981, Depopulation and repopulation of the R1H-rhabdomyosarcoma of the rat after x-irradiation. European Journal of Cancer, 17, 375-386.
10. JUNG, H., KRÜGER, H. J., BRAMMER, I., ZYWIETZ, F. and BECK-BORNHOLDT, H. P., 1990, Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single dose of X-rays. International Journal of Radiation Oncology, Biology, Physics, 53, 567-589.
11. KERN, K. A., BRUNETTI, A., NORTON, J. A., CHANG, A. E., MALAWER, M., LACK, E., FINN, R. D., ROSENBERG, S. A. and LARSON, S. M., 1988, Metabolic imaging of human extremity musculoskeletal tumors by PET. Journal of Nuclear Medicine, 29, 181-186.
12. KESSLER, R. M., ELLIS, J. R. and EDEN, M., 1984, Analysis of emission tomographic scan data: Limitations imposed by resolution and background. Journal of Computer Assisted Tomography, 8, 514-522.
13. KEYES, J. W. JR, 1995, SUV: standard uptake or silly useless value? Journal of Nuclear Medicine, 36, 1836-1839.
14. KIM, H. J., BOYD, J., DUNPHY, F. and LOWE, V., 1998, F-18 FDG PET scan after radiotherapy for early stage larynx cancer. Clinical Nuclear Medicine, 23, 750-752.
15. KINKEL, K., LU, Y., BOTH, M., WARREN, R. S. and THOENE, R. F., 2002. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta analysis. Radiology, 224, 748-756.
16. LANG, T. A. and SECIC, M., 1997, How to Report Statistics in Medicine (Philadelphia: American College of Physicians).
17. 18F-FDG PET using a simple visual analysis of tumor characteristics in patients with cervical cancer. Journal of Nuclear Medicine, 44, 192-197.
18. MINN, H., LESKINEN-KALLIO, S., LINDHOLM, P., BERGMAN, J., RUOTSALAINEN, U., TERÄS, M. and HAAPARANTA, M., 1993, (18-F) fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin. Journal of Computer Assisted Tomography, 17, 115-123.
19. NEWMAN, J. S., FRANCIS, I. R. and KAMINSKI, M.. S., 1994, Imaging of lymphoma with PET with 2-(F-18)-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology, 190, 111-116.
20. 11C]methionine-positron emission tomography. Radiotherapy and Oncology, 52, 225-232.
21. OZOLS, R. F., IHDE, D. C., LINEHAN, W. M., JAKOB, J., OSTCHEGA, Y. and YOUNG, R. C., 1988, A randomized trial of standard chemotherapy versus high-dose chemotherapy regimen in the treatment of poor prognosis germ cell tumour. Journal of Clinical Oncology, 6, 1031-1040.
22. RAABE, A. and BECK-BORNHOLDT, H. P., 1994, Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H-tumour. Radiotherapy and Oncology, 30, 254-262.
23. RAABE, A., QUAESTER, S., DUBBEN, H. H., ZIERON, J., KRÜLL, A., ALBERTI, W. and BECK-BORNHOLDT, H. P., 2001, Impact of a concomitant boost and its timing on the response of the rhabdomyosarcoma R1H of the rat to fractionated irradiation. Strahlentherapie und Onkologie, 177, 362-366.
24. REINHARDT, M. J., KUBOTA, K., YAMADA, S., IWATA, R. and YAEGASHI, H., 1997, Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. Journal of Nuclear Medicine, 38, 280-287.
25. SAKAMOTO, H., NAKAI, Y., OHASHI, Y., MATSUDA, M., SAKASHITA, T., NASAKO, Y., KITAYAMA, H., KAWABE, J., OKAMURA, T. and OCHI, H., 1998, Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas. Acta Otolaryngologica, 538, 254-260.
26. SCHECHTER, N. R., GILLENWATER, A. M., BYERS, R. M., GARDEN, A. S., MORRISON, W. H., NGUYEN, L. N., PODOLOFF, D. A. and ANG, K. K., 2001, Can positron emission tomography improve the quality of care for head-and-neck cancer patients. International Journal of Radiation Oncology, Biology, Physics, 51, 4-9.
27. SMITH, T. A. D., 1998, FDG uptake, tumour characteristics and response to therapy: a review. Nuclear Medicine Communications, 19, 97-105.
28. SOM, P., ATKINS, H. L., BANDOYPADYAY, D., FOWLER, J. S., MATSUI, K., OSTER, Z. H., SACKER, D. F., SHIUE, C. Y., TURNER, H., WAN, C. N., WOLF, A. P. and ZABINSKI, S. V., 1980, A fluorinated glucose analog, 2-fluoro-2-deoxy-D- glucose: nontoxic tracer for rapid tumor detection. Journal of Nuclear Medicine, 21, 670-675.
29. STRAUSS, L. G. and CONTI, P. S., 1991, The applications of PET in clinical oncology. Journal of Nuclear Medicine, 32, 623-648.
30. TATSUMI, M., NAKAMOTO, Y., TRAUGHBER, B., MARSHALL, L. T., GESCHWIND, J.-F. H. and WAHL, R. L., 2003, Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose. Cancer Research, 63, 6252-6257.
31. 18F]fluorodeoxyglucose in management of recurrent colorectal cancer. Archives of Surgery, 134, 503-511.
32. VOGLER, H. and BECK-BORNHOLDT, H. P., 1988, Radiobiology of the rhabdomyosarcoma R1H of the rat: kinetics of cellular inactivation by fractionated irradiation. International Journal of Radiation Oncology, Biology, Physics, 14, 317-325.
33. WARBURG, O., 1931, The Metabolism of Tumours (New York: Richard R. Smith).
34. WÜRSCHMIDT, F., BECK-BORNHOLDT. H. P. and VOGLER, H., 1990, Radiobiology of the rhabdomyosarcoma R1H of the rat: influence of the size of radiation field on tumour response, tumour bed effect and neovascularization. International Journal of Radiation Oncology, Biology, Physics, 18, 879-882.
35. WÜRSCHMIDT, F., BECK-BORNHOLDT, H. P., VOGLER, H. and JUNG. H., 1991, Radiotherapy of the rhabdomyosarcoma R1H of the rat: split-course versus continuous fractionation. Strahlentherapie und Onkologie, 167, 26-30.